Literature DB >> 25231758

Preserving residual renal function in dialysis: what we know.

Nikunjkumar Patel1, Susie L Hu.   

Abstract

Residual renal function confers a survival benefit among dialysis patients thought to be related to greater volume removal and solute clearance. Whether the presence of residual renal function is protective or merely a marker for better health is not clear. The basic mechanisms governing the decline or persistence of residual renal function are poorly understood and few studies have examined the role of medical therapy in its preservation. Dialysis modality, inflammatory processes often associated with comorbid diseases (including diabetes mellitus and obesity), volume dysregulation, and vitamin D deficiency are predictive of residual renal function decline. We review potential mechanisms for preservation of remaining glomerular filtration rate among chronic dialysis patients.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25231758     DOI: 10.1111/sdi.12302

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  7 in total

Review 1.  Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease.

Authors:  Xin Liu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2016-09-07

Review 2.  On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.

Authors:  Cem Tanriover; Duygu Ucku; Carlo Basile; Katherine R Tuttle; Mehmet Kanbay
Journal:  J Nephrol       Date:  2022-07-11       Impact factor: 4.393

Review 3.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.

Authors:  Ling Zhang; Xiaoxi Zeng; Ping Fu; Hong Mei Wu
Journal:  Cochrane Database Syst Rev       Date:  2014-06-23

Review 4.  Preoperative Evaluation in Patients With End-Stage Renal Disease and Chronic Kidney Disease.

Authors:  Rabih Nasr; Sridhar Chilimuri
Journal:  Health Serv Insights       Date:  2017-06-28

5.  Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis.

Authors:  Tong Wu; Yuanyuan Qi; Shuang Ma; Lijie Zhang; Xinyu Pu; Kui Chen; Ying Zhao; Shenghua Sang; Jing Xiao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

6.  Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis.

Authors:  Jenny I Shen; Anjali B Saxena; Maria E Montez-Rath; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

7.  Feasibility of Incremental 2-Times Weekly Hemodialysis in Incident Patients With Residual Kidney Function.

Authors:  Andrew I Chin; Suresh Appasamy; Robert J Carey; Niti Madan
Journal:  Kidney Int Rep       Date:  2017-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.